Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics, Inc. (LXEO) Cash from Operations (2022 - 2023)

Lexeo Therapeutics' Cash from Operations history spans 2 years, with the latest figure at 13981000.0 for Q4 2023.

  • For Q4 2023, Cash from Operations rose 15.91% year-over-year to 13981000.0; the TTM value through Dec 2023 reached 59496000.0, changed N/A, while the annual FY2024 figure was 81151000.0, 36.4% down from the prior year.
  • Cash from Operations for Q4 2023 was 13981000.0 at Lexeo Therapeutics, roughly flat from 13949000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 13192000.0 in Q2 2023 and bottomed at 18374000.0 in Q1 2023.